Postdoc @ Harvard HSCRB and the Broad Institute.

Boston, MA
Joined July 2012
Patrick Griffin retweeted
Our paper is out in @NatureAging. We looked for factors that make old cells' gene expression young without erasing their identity. SRSF1 came out as a promising rejuvenation target that reduced aging hallmarks in human cells and extended median lifespan of aged mice by 14%. 1/4
8
40
5
131
6,790
Patrick Griffin retweeted
Today we announced interim data from our first-in-human, Phase 1 clinical trial evaluating our lead program in optic neuropathies, showing it was well-tolerated by 3 participants with glaucoma. Read more about our safety & visual field observations here:bit.ly/4ASWq0p
24
94
37
555
76,733
Patrick Griffin retweeted
1/ Excited to share our new preprint from a joint collaboration between @JswLab + @Bruce_Ksander! Aging is marked by a progressive loss of resilience to stress. Can we systematically search the human ORFome for genes that make vulnerable cells more resilient? Performing such a genome-scale ORF screen led us to NKX2-5—a heart transcription factor we engineered to restore vision, and improve health in aged mice. A breakdown🧵 🔗 doi.org/10.64898/2026.09.29.…
11
50
8
237
51,095
Patrick Griffin retweeted
Infinite Epigenetics & True Diagnostics acquire @sinclairfriends lab spin-out, Tally, giving them access to DNAme IP to help bring down costs & accelerate epigenetics-informed health care Congrats to @L_Catterton, @melanie_goldey, @patrick_griffN, @gladyshev_lab & the entire team! 👏
10
25
2
227
28,062
Patrick Griffin retweeted
It takes two (transcription factors) to tango Transcription factor collaboration enables precise T cell state engineering tinyurl.com/tcelltfs Excited to share our preprint with @JD_Buenrostro, @cgersbach, and an incredible team of collaborators as part of @IGVFConsortium 🧵
2
61
5
224
30,533
Patrick Griffin retweeted
Excited to share my postdoc work with @JD_Buenrostro now out in @Nature! "Epigenetic memory of colitis promotes tumour growth" nature.com/articles/s41586-0… We wanted to understand how transient inflammation can create a long-lived increase in cancer risk, even after full recovery 🧵
11
78
10
369
68,290
Patrick Griffin retweeted
First test of partial epigenetic reprogramming to reverse aging for two eye conditions (glaucoma and NAION) gets FDA go ahead @lifebiosciences Based on 2020 @Nature paper pubmed.ncbi.nlm.nih.gov/3326… endpoints.news/exclusive-fda…
19
188
15
795
59,390
Patrick Griffin retweeted
Huge thanks to all co-authors and the inimitable @JD_Buenrostro for supporting this new direction - I got to think about evolution, engineering, chromatin biophysics, and modeling during the course of this project. For more, check out the preprint: biorxiv.org/content/10.1101/…
1
7
49
3,430
Patrick Griffin retweeted
Excited to share a short article I wrote describing: Slide-tags - which enables spatial single-nucleus sequencing, allowing us to dive deeper into the complexity of tissue organization. Grateful for the amazing team and support from @insitubiology and @macosko! #ToolsOfTheTrade
7
41
6,187
Patrick Griffin retweeted
The latest LLLM (large language of life) foundation model, with state-of-the art chronological age estimation, prediction of outcomes, and performance across different datasets and conditions
Excited to share CpGPT, a new foundation model for DNA methylation, crafted to understand the 'language' of epigenetics! 🧬🤖 What’s CpGPT? CpGPT is a transformer model pre-trained on CpGCorpus, a huge dataset of public DNA methylation info. By integrating sequence, positional, and epigenetic data, it captures complex epigenetic interactions from even a small part of the methylome. 📄 Preprint: biorxiv.org/cgi/content/shor… Why CpGPT? DNA methylation is key for gene expression and chromatin structuring, with CpG sites often varying in diseases like cancer and aging. Here’s what sets CpGPT apart: ✨ CpGPT Highlights: 🔧 Deep Pretraining: Trained on over 100K samples from 1,500+ studies, covering 1M+ CpG sites. 🗺️ Zero-Shot Skills: CpGPT imputes methylation from minimal data, mapping different Illumina arrays to a common reference. 🐭 Cross-Mammalian Reach: When fine-tuned, CpGPT accurately imputes methylation in new mammalian species. 📈 Strong Performance: Fine-tuned CpGPT ranks 2nd overall and 1st on the public leaderboard for age and mortality prediction in the Biomarkers of Aging Challenge. Special shoutout to Lucas (@ollimacsacul) for his outstanding leadership on this project! Big thanks as well to all the co-authors (@rv_sehgal, @prof_horvath, etc.) for their dedication and swift feedback throughout. We're committed to open science and are actively preparing the code. Expect the full code and model weights to be available soon—likely within the next few weeks!
41
3
132
46,948
Patrick Griffin retweeted
Introducing IN SITU GENOME SEQUENCING, a new technology to resolve DNA sequence🧬 and structure🔬 A team effort with @Andrew_C_Payne, @PaulReginato, @eboyden3, @JD_Buenrostro, and Fei Chen science.sciencemag.org/conte… This is how it works: (1/8)
12
529
117
1,310
Thrilled to see our ExIGS tool featured! A true testament to the power of collaboration. Huge congrats to the team for their hard work! 🧬@ajaylabade31 @z_chiang @CarolineComenho nature.com/articles/d41586-0…
1
27
1
116
11,528
Patrick Griffin retweeted
T cells become exhausted and fail to control tumors in cancer patients. What if we could replicate T cell exhaustion in vitro and uncover the gene regulatory network driving exhaustion, enabling immuno-oncology drug discovery? With AstraZeneca, the Buenrostro lab addresses this gap (biorxiv.org/content/10.1101/…):
1
38
1
131
21,431
Study Proposes Framework to Standardize Biomarkers of Aging and Accelerate Clinical Use @jpoganik Read more: buff.ly/3OMHMBo
1
3
3
776
We are recruiting postdoctoral fellows in neurobiology and development to complement our group specializing in genomic technologies, epigenetics and machine learning. projects are very well funded and we are interested in co-mentorship. Please DM if interested in hearing more!
3
51
3
116
36,760
Our latest paper is out - a new method called "TIME-Seq" to measure biological age for just a few dollars. Great work Patrick Griffin! @NatureAging Free download rdcu.be/dvDfc
30
140
12
783
93,808
Patrick Griffin retweeted
Can we reverse aging? 7 yrs ago, Ocampo et al. showed that partial reprogramming can ameliorate aging hallmarks. But, OSKM induction has safety limitations & no new factors have emerged since. Here, biorxiv.org/content/10.1101/… we used 🧬 screens to find new rejuvenation factors🧵1/8
8
73
21
161
49,157
Patrick Griffin retweeted
Delving into our newly released result, a thread:
Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma: A year-long functional tracking of in vivo partial reprogramming demonstrates safety and efficacy. Work from @margaretekarg @YuanchengLu @davidasinclair @bruce_ksander liebertpub.com/doi/10.1089/c…
11
19
4
107
90,097
Patrick Griffin retweeted
Can we shield the epigenome from age-related changes, much like how SIRT6 defends the genome? Using a CRISPRi screening approach, @XiaoTianPhD seeks to identify genes involved in maintaining epigenome stability. His new lab @sbpdiscovery is recruiting for various roles!
1
8
1
51
9,411